In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefodizime Sodium Drug Master File in Korea (Cefodizime Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefodizime Sodium. The MFDS reviews the Cefodizime Sodium KDMF as part of the drug registration process and uses the information provided in the Cefodizime Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefodizime Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefodizime Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefodizime Sodium suppliers with KDMF on PharmaCompass.